Learn More
The olfactory bulb as the entry site for prion-like propagation in
neurodegenerative diseases
Learn More

Diabetes drug slows experimental Parkinson’s disease progression,
human trials to begin next year



Patrik Brundin Laboratory
Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit
to patients and their caregivers.

Learn More


Tune in to Van Andel Institute's Facebook live World Parkinson's Day panel now! ... See MoreSee Less

World Parkinson’s Day panel discussion: Exploring the latest in research and treatment

View on Facebook

Just over an hour until Van Andel Institute's Facebook Live panel discussion on the latest Parkinson's research starts! Head on over to Van Andel Institute's Facebook page at 11:30 a.m. EST to join! ... See MoreSee Less

Today’s the day! Our World Parkinson's Day panel discussion goes live at 11:30 a.m. EST right here on the VAI Facebook page. We hope you tune in!

View on Facebook